Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07482033
Eligibility Criteria:
Inclusion Criteria
* Age 18 years or older
* Diagnosed with chronic obstructive pulmonary disease (COPD) at least one year prior
* Currently receiving treatment with noninvasive mechanical ventilation (NIMV) support
* Ability to communicate verbally and in writing in a clear and sustainable manner
* No severe visual or hearing impairment that would prevent understanding of educational materials
* Basic ability to use a smartphone
* Active use of the WhatsApp application on a personal smartphone
* Technical capability to view educational materials sent via phone (e.g., internet access, video playback)
* No prior education on NIMV delivered using the Pecha Kucha presentation technique
* Adequate cognitive function to allow independent participation (e.g., no history of dementia or confusion)
* Availability to attend educational and assessment sessions as scheduled
Exclusion Criteria
* Failure to attend planned educational sessions or inability to complete the study protocol
* Voluntary withdrawal from the study, declared verbally or in writing
* Death during the study period
* Development of a serious health condition preventing continuation in the education program (e.g., hospitalization, acute exacerbation, deterioration in mental status)
* Loss of phone or internet access preventing receipt of educational materials
* Significant communication problems that substantially interfere with participation in the educational process
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Days
Study:
NCT07482033
Study Brief:
Protocol Section:
NCT07482033